Home » Topics » BioWorld Science

BioWorld Science
RSS

Statins improve venetoclax anticancer activity in hematologic malignancies

June 22, 2018

Dual MetAP 2/DPP-IV inhibitors identified at Lilly

June 22, 2018

Bristol-Myers Squibb describes glycogen synthase kinase 3 inhibitors

June 22, 2018

New dUTPase inhibitors synthesized at CV6 Therapeutics

June 22, 2018

MaaT Pharma enters agreement for GvHD microbiome therapy

June 22, 2018

Researchers present primary efficacy data on PRO-140 from CD02 study

June 22, 2018

HTX-011 receives breakthrough therapy designation and reaches primary endpoint in phase IIb studies

June 22, 2018

First-in-human data presented for novel monoclonal anti-IL-6R-alpha antibody BCD-089

June 22, 2018

Preliminary data presented from first-in-human phase I trial on MTL-CEBPA

June 22, 2018

Reata initiates first-in-human study with allosteric RORgammat inhibitor RTA-1701

June 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...